01 / 03
Market Entry Feasibility Assessment
Rigorous evaluation of commercial viability, regulatory pathway, reimbursement landscape and competitive positioning before you commit capital to Colombia.
Strategic market access, stakeholder engagement and commercial intelligence for healthcare innovators seeking growth opportunities in Latin America.
Each engagement is principal-led and structured around clear deliverables, milestone reviews and measurable commercial outcomes.
Rigorous evaluation of commercial viability, regulatory pathway, reimbursement landscape and competitive positioning before you commit capital to Colombia.
Evidence-based plans to drive KOL engagement, guideline inclusion and clinician uptake across oncology, genomics and precision medicine programs.
On-the-ground commercial presence — distributor identification, hospital network access, payer negotiation and stakeholder representation on your behalf.
Diego Rodríguez is a healthcare professional with extensive experience in oncology, molecular diagnostics, precision medicine, market access and business development across Colombia and Latin America.
He partners directly with international leadership teams — translating complex local clinical, regulatory and commercial dynamics into a clear, executable growth plan.
Nexa Precision Advisory works with a small number of international companies at any one time — ensuring discretion, senior attention and execution quality.
Senior healthcare expertise across oncology, molecular diagnostics and precision medicine.
Direct relationships with clinical, academic and payer stakeholders.
Boutique engagement model — principal-led, no junior hand-offs.
Aligned incentives focused on measurable commercial outcomes.
A thirty-minute call to understand your objectives in Colombia, share an initial perspective on the opportunity, and determine whether a deeper engagement is appropriate.